Clinical End Points in Coronary Stent Trials

Cutlip et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69d56e1375589c71d767d35e — DOI: https://doi.org/10.1161/circulationaha.106.685313

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction· 2008 · 342 citations
2. Frequency of intracoronary filling defects by angiography in Angina pectoris at rest· 1985 · 186 citations
3. Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents· 2006 · 1,301 citations
4. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study· 2007 · 1,758 citations
5. Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents· 2006 · 141 citations